...
首页> 外文期刊>Frontiers in Cardiovascular Medicine >Feasibility of CardioSecur®, a Mobile 4-Electrode/22-Lead ECG Device, in the Prehospital Emergency Setting
【24h】

Feasibility of CardioSecur®, a Mobile 4-Electrode/22-Lead ECG Device, in the Prehospital Emergency Setting

机译:PardioseCur®,移动式4电极/ 22引导ECG设备的可行性,在预休息室紧急情况下

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: This study explores the application of CardioSecur® (CS-ECG), a hand-held 4-electrode/22-lead ECG-device, in comparison with conventional 12-lead electrocardiogram (c12L-ECG) in patients with acute chest pain in the prehospital emergency setting. Methods: CS-ECG systems were provided for two physician-staffed emergency ambulances and parallel recordings of c12L-ECG and CS-ECG were obtained from all patients with acute chest pain. Treating emergency physicians were asked to evaluate the CS-ECG system with a standardized questionnaire. Following study completion, acquired ECGs were analyzed separately by two independent cardiologists blinded to all other medical records. Results: Over a period of 20 months a total of 203 patients were included in our study. According to a standardized questionnaire, 79% of emergency medical professionals preferred application of CS-ECG, with 87% of teams judging CS-ECG to be beneficial for patients. Morover, 79% of physicians reported a reduction in time to definitive diagnosis with implementation of CS-ECG. The majority of professional users attested user-friendliness and feasibility of CS-ECG in terms of easy general handling (94%), application (93%) and placement of electrodes (98%). During prehospital triage, both c12L-ECG and CS-ECG correctly identified 31 (91%) patients with ST-elevation myocardial infarction (STEMI). Conclusion: In this first pilot study, implementation of the CardioSecur®-ECG system in the prehospital emergency setting demonstrated feasibility and user-friendliness so that emergency teams generally preferred CS-ECG to c12L-ECG. Diagnostic yield of CS-ECG was similar to c12L-ECG recordings.
机译:背景:本研究探讨了CardioseCur®(CS-ECG),手持式4电极/ 22引导ECG装置的应用,与急性胸部疼痛的患者中的常规12引导心电图(C12L-ECG)相比在预孢子紧急情况下。方法:为两名医师的工作人员的应急救护车提供CS-ECG系统,并从所有急性胸痛的患者中获得C12L-ECG和CS-ECG的并联录像。要求治疗紧急医生用标准化问卷评估CS-ECG系统。在研究完成之后,通过向所有其他医疗记录蒙蔽的两个独立的心脏病学家分别分别对被收购的ECG分析。结果:在我们的研究中,共有203名患者的20个月内。根据标准化问卷,79%的紧急医疗专业人员首选申请CS-ECG,87%的团队判断CS-ECG对患者有益。 Morover,79%的医生报告了随着CS-ECG实施的确定性诊断。大多数专业用户在易于一般处理(94%),申请(93%)和电极的放置方面,证明了CS-ECG的用户友好性和可行性(98%)。在前孢子术期间,C12L-ECG和CS-ECG都正确鉴定了31例(91%)的ST升高心肌梗死患者(STEMI)。结论:在第一个试点研究中,在预休斯科尔®-ecg系统的实施中,在预孢子紧急情况下表现出可行性和用户友好性,使紧急团队通常优选CS-ECG至C12L-ECG。 CS-ECG的诊断产量类似于C12L-ECG录制。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号